Mounjaro (tirzepatide) online prescriptions

Mounjaro is a peptide-based drug that has been designed to treat type 2 diabetes. It works by mimicking the effects of certain hormones in the body, such as GLP-1 and GIP, which help regulate appetite and glucose levels. Mounjaro also decreases ghrelin levels, thereby reducing hunger sensations and cravings. In clinical trials, it has been shown to reduce weight and improve glycemic control in patients with type 2 diabetes. Furthermore, Mounjaro is safe for long-term use, with minimal side effects reported so far.

Mounjaro was approved for use by the FDA as a treatment for type 2 diabetes in 2022. It is also available under the brand name Zepbound, which is indicated for obesity.

Mounjaro is a prescription medication approved by the FDA to help patients manage type 2 diabetes. It is also used off-label for weight loss in patients with overweight or obesity. It is not intended for use in people with type 1 diabetes or diabetic ketoacidosis. Mounjaro is often prescribed when lifestyle changes, diet, and exercise alone cannot effectively control blood sugar levels.

In some cases, Mounjaro may be prescribed to patients with obesity or overweight individuals with weight-related medical problems such as type 2 diabetes, high blood pressure, obstructive sleep apnea, or cardiovascular disease.

Mounjaro is an innovative peptide-based drug designed to treat type 2 diabetes. It works by mimicking the effects of certain hormones in the body, such as GLP-1 and GIP, which help regulate appetite and glucose levels. It belongs to a classification of medication known as glucagon-like peptide-1 (GLP-1) receptor agonists.

By mimicking GLP-1 and GIP, Mounjaro works to control glucose levels in the body. Overall, this helps regulate blood sugar levels and reduce body weight in patients with type 2 diabetes.

It should be noted that Mounjaro is not a cure for type 2 diabetes. It helps patients manage their blood sugar levels by reducing glucose in the blood, but will not reverse the condition. Mounjaro is prescribed in conjunction with lifestyle alterations (like diet changes and increased physical activity) as a comprehensive treatment program for type 2 diabetes.

Mounjaro has been shown to cause adverse side effects in some patients. If these reactions become severe or do not go away after a few days, seek medical attention right away.

Mild side effects reported from Mounjaro use include:

• Upset stomach
  
• Gas
  
• Constipation
  
• Diarrhea
  
• Nausea
  
• Indigestion
  
• Loss of appetite
  
• Injection site reaction
  
  

More serious side effects include:

• Severe stomach pain
  
• Vomiting
  
• Hives
  
• Difficulty breathing
  
• Changes in heartbeat
  
• Fever
  
• Skin rash
  
• Heartburn
  
• Swelling
  
• Pancreatitis
  
• Gallbladder disease
  
• Low blood sugar
  
  

If you experience any of these side effects, seek medical attention immediately. These are symptoms of a possibly serious adverse reaction to this medication and require treatment right away.

In both male and female rats, Mounjaro has been linked to the development of thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is unknown whether or not Mounjaro causes these tumors in humans. However, Mounjaro is contraindicated in patients with a personal or family history of MTC. It is also contraindicated in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Patients with these conditions may receive counseling from their healthcare provider about the risks associated with Mounjaro use.

As with all medication, inform your doctor of any medical conditions you are currently managing. Tell them about any and all medication, prescription drugs, and supplements you are taking before starting treatment with Mounjaro. Mounjaro can interact with substances in the body, causing potentially serious adverse reactions.

Tell your doctor if you have had pancreas or kidney disease, as well as any stomach/ digestive problems you have.

In addition, let your doctor know if you are planning to become pregnant, are pregnant, or are currently breastfeeding before starting treatment with this medication. Call your provider if you become pregnant while you are taking Mounjaro.

Mounjaro is commonly supplied as a liquid solution that is injected just below the skin. For most patients, Mounjaro injections are administered once a week for 4 weeks. The dosage may be adjusted as needed after this time. You will be taught how to use the medicine at home by your healthcare provider. Injection sites should be rotated with each weekly injection. Do not use the same site each time. The specific dosage of Mounjaro prescribed depends on the patient’s blood sugar levels, age, and body weight. Take this medication exactly as ordered. Do not increase or discontinue the dosage without consulting with your healthcare provider first.

Keep all medication bottles out of reach of small children. Store in the original carton under refrigerated conditions between 36 and 46 degrees Fahrenheit. Protect from light. Do not freeze; do not use if frozen. If needed, the single-dose pen can be stored unrefrigerated at temperatures not exceeding 86 degrees Fahrenheit for up to 21 days. Avoid exposing the medication to excess heat or moisture.

If you begin to notice any adverse side effects like those listed above, notify your healthcare provider immediately.

Mounjaro is currently only available via prescription. This means that a licensed healthcare provider must authorize the use of this medication.

If you are looking for a prescription, doctors on Sesame can write a prescription–or refill an existing one–during a virtual or in-person visit. Note that not all drugs can be prescribed via an online video appointment. In some cases, an in-person doctor visit is required for a prescription.

Book an appointment with a provider on Sesame today to discuss whether or not Mounjaro is right for you.

Note that all prescriptions are at the discretion of your healthcare provider. Sesame cannot guarantee that you will be provided a prescription after a video or in-person appointment. Providers on Sesame are unable to prescribe controlled substances. For more information about controlled substances, check out the Drug Enforcement Agency’s scheduling guidelines here.

Providers on Sesame can write a prescription for Mounjaro to be picked up near you–often within the same day. Don’t wait to get your prescription filled. Talk to a provider on Sesame and get your prescription ordered right away for fast and convenient pickup from a pharmacy of your choice.

Note that all prescriptions are at the discretion of your healthcare provider.

Sesame’s online weight loss program is a subscription that renews every 3 months and includes a video consultation with a weight loss provider, a prescription for semaglutide, liraglutide, tirzepatide, or other weight loss medication if deemed clinically appropriate, assistance with pre-authorization for medication coverage, and 90 days of unlimited messaging with your provider.

Sesame does not accept insurance in order to keep prices low and transparent, which means that the cost of the weight program will not be covered by insurance. It's important to note that the cost of medication is not included in this program, and Sesame does not guarantee medication pricing or insurance coverage for medication.

In addition, most insurance companies will not cover the off-label use of prescription drugs. __That means you will likely not be able to get insurance coverage if you are prescribed:

• Ozempic
  
• Rybelsus
  
• Mounjaro
  
• Victoza
  
  

If you are uninsured, please be aware that GLP-1 medications like Wegovy can be expensive, typically ranging between $950 to $1,600 per month. If you are insured, your provider can assist with insurance pre-authorization paperwork to cover the cost of your medication.

Your provider may order a metabolic panel if you do not have recent metabolic testing data available. If this is the case, the price of your lab test is not included in the program cost.

Certain GLP-1 therapies such as semaglutide (the active ingredient in Ozempic and Wegovy), liraglutide (the active ingredient in Saxenda and Victoza), and tirzepatide (the active ingredient in Mounjaro and Zepbound) may increase the likelihood of developing thyroid gland tumors, including medullary thyroid carcinoma (MTC), a type of thyroid cancer. This conclusion is based on studies where laboratory animals given semaglutide, liraglutide and tirzepatide developed tumors. However, it is not yet confirmed whether semaglutide, liraglutide and tirzepatide pose the same risk to humans.

It’s important to inform your doctor if you or any family member has ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a condition leading to tumors in multiple glands. If this is the case, your doctor will likely advise against taking GLP-1 medications such as semaglutide, tirzepatide or liraglutide.

If you are prescribed a GLP-1 medication such as Ozempic, Wegovy, Mounjaro or Saxenda and exhibit any of the following symptoms, you should contact your provider immediately:

• A lump or swelling in the neck
• Hoarseness
• Difficulty swallowing
• Shortness of breath
  
  

Before taking GLP-1 medications, you should also discuss the following with your provider:

• Allergies: Inform your doctor and pharmacist of any allergies you have to semaglutide (including under brand names Ozempic, Rybelsus, Wegovy) or similar medications such as tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide (Bydureon, Byetta), liraglutide (Saxenda, Victoza, or in Xultophy), and lixisenatide (Adlyxin, or in Soliqua).
• Personal and family medical history: Be sure to disclose if you have a history of conditions like pancreatitis, diabetic retinopathy, gallbladder disease, or kidney disease. Inform your doctor about recent episodes of diarrhea, nausea, or vomiting, or any inability to consume liquids, which could lead to dehydration.
• Current Medications and Supplements: Provide a comprehensive list of all medicines and supplements you are currently taking, including prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products. This is crucial as GLP-1 medications can alter how your body absorbs oral medications.
• Pregnancy and Breastfeeding: Inform your doctor if you are pregnant, breastfeeding, or planning to become pregnant soon.
• Surgical procedures: In the event of surgery, including dental procedures, inform the medical or dental professional that you are on GLP-1 medication.
  
  

It's essential to thoroughly discuss these risks with your healthcare provider and consider your personal and family medical history when deciding whether to use these medications. Your doctor can provide guidance on the best course of action based on your specific health situation.